← 產業報告目錄
Plasma Fractionation Market Size, Share & Trends Analysis Report By Products (Coagulation Factors, Albumin, Protease Inhibitors, and Other Products), By Applications, By End-Users, Region And Segment Forecasts, 2023-2031.
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-13頁數 180報告編號 INSIGHTACE-f31aa2620a
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Plasma Fractionation Market is positioned for steady expansion, with a projected CAGR of 6.4% from 2023 to 2031.
The Plasma Fractionation sector involves extraction of multiple parts of plasma, a component of blood acquired through blood fractionation. This domain has witnessed notable transformation owing to technological breakthroughs and shifting healthcare dynamics.
Growth is fueled by a convergence of factors: rising awareness among end users, continuous product innovation, and the expanding emphasis on efficiency and sustainability within the healthcare sector.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
From a regional perspective, mature markets in North America and Europe continue to hold notable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and expanding investment in the sector.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Plasma Fractionation Market Snapshot
Chapter 4. Global Plasma Fractionation Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Market Share Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. COVID 19 Impact Analysis
Chapter 5. Market Segmentation 1: By Products, Estimates & Trend Analysis
5.1. By Products, & Market Share, 2019 & 2030
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 for the following By Products:
5.2.1. Immunoglobulins
5.2.1.1. Intravenous Immunoglobulins
5.2.1.2. Subcutaneous Immunoglobulins
5.2.1.3. Others
5.2.2. Coagulation Factors
5.2.3. Albumin
5.2.4. Protease Inhibitors
5.2.5. Other Products
Chapter 6. Market Segmentation 2: By Applications Estimates & Trend Analysis
6.1. By Applications & Market Share, 2019 & 2030
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 for the following By Applications:
6.2.1. Immunology
6.2.2. Hematology
6.2.3. Neurology
6.2.4. Critical Care
6.2.5. Hemato-Oncology
6.2.6. Rheumatology
6.2.7. Other Applications
Chapter 7. Market Segmentation 3: By End-Users Estimates & Trend Analysis
7.1. By End-Users & Market Share, 2019 & 2030
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 for the following By End-Users:
7.2.1. Hospitals& Clinics
7.2.2. Clinical Research Laboratories
7.2.3. Academic Institutes
Chapter 8. Plasma Fractionation Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Plasma Fractionation Market revenue (US$ Million) estimates and forecasts By Products, 2019 - 2030
8.1.2. North America Plasma Fractionation Market revenue (US$ Million) estimates and forecasts By Applications, 2019 - 2030
8.1.3. North America Plasma Fractionation Market revenue (US$ Million) estimates and forecasts By End-Users, 2019 - 2030
8.1.4. North America Plasma Fractionation Market revenue (US$ Million) estimates and forecasts by country, 2019 - 2030
8.2. Europe
8.2.1. Europe Plasma Fractionation Market revenue (US$ Million) By Products, 2019 - 2030
8.2.2. Europe Plasma Fractionation Market revenue (US$ Million) By Applications, 2019 - 2030
8.2.3. Europe Plasma Fractionation Market revenue (US$ Million) By End-Users, 2019 - 2030
8.2.4. Europe Plasma Fractionation Market revenue (US$ Million) by country, 2019 - 2030
8.3. Asia Pacific
8.3.1. Asia Pacific Plasma Fractionation Market revenue (US$ Million) By Products, 2019 - 2030
8.3.2. Asia Pacific Plasma Fractionation Market revenue (US$ Million) By Applications, 2019 - 2030
8.3.3. Asia Pacific Plasma Fractionation Market revenue (US$ Million) By End-Users, 2019 - 2030
8.3.4. Asia Pacific Plasma Fractionation Market revenue (US$ Million) by country, 2019 - 2030
8.4. Latin America
8.4.1. Latin America Plasma Fractionation Market revenue (US$ Million) By Products, (US$ Million)
8.4.2. Latin America Plasma Fractionation Market revenue (US$ Million) By Applications, (US$ Million)
8.4.3. Latin America Plasma Fractionation Market revenue (US$ Million) By End-Users, (US$ Million)
8.4.4. Latin America Plasma Fractionation Market revenue (US$ Million) by country, (US$ Million) 2019 - 2030
8.5. Middle East & Africa
8.5.1. Middle East & Africa Plasma Fractionation Market revenue (US$ Million) By Products, (US$ Million)
8.5.2. Middle East & Africa Plasma Fractionation Market revenue (US$ Million) By Applications, (US$ Million)
8.5.3. Middle East & Africa Plasma Fractionation Market revenue (US$ Million) By End-Users, (US$ Million)
8.5.4. Middle East & Africa Plasma Fractionation Market revenue (US$ Million) by country, (US$ Million) 2019 - 2030
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. CSL Limited
9.2.2. Grifols, S.A.
9.2.3. Octapharma AG
9.2.4. Kedrion S.P.A.
9.2.5. Shire Plc (Subsidiary of Takeda Pharmaceutical Company Limited)
9.2.6. Biotest AG
9.2.7. China Biologic Products Holdings, Inc.
9.2.8. Bio Products Laboratory (BPL) Ltd
9.2.9. Japan Blood Products Organization
9.2.10. Shanghai RAAS Blood Products Co., Ltd.
9.2.11. Other Prominent Player
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們